Publications
- Inhibition of RANKL in the therapy of osteoporosis2012 | First Faculty of Medicine
- Denosumab in postmenopausal osteoporosis2011 | First Faculty of Medicine
- Denosumab: fast inhibition and fast reversibility of osteoclast function and safety and efficacy in the elderly2011 | First Faculty of Medicine
- Denosumab in the treatment ofpostmenopausal osteoporosis and prevention of fractures2010 | First Faculty of Medicine
- Bone as a remodeling tissue2010 | First Faculty of Medicine
- Marker of bone resorption in acute response to exogenous or endogenous parathyroid hormone2008 | First Faculty of Medicine
- Interindividual differences contribute to variation in microbiota composition more than hormonal status: A prospective study2023 | First Faculty of Medicine
- A decrease in serum 1,25(OH)(2)D after elective hip replacement and during bone healing is associated with changes in serum iron and plasma FGF232022 | First Faculty of Medicine, Third Faculty of Medicine
- Menopausal Transition: Prospective Study of Estrogen Status, Circulating MicroRNAs, and Biomarkers of Bone Metabolism2022 | First Faculty of Medicine
- Treatment of postmenopausal osteoporosis patients with teriparatide for 24 months reverts forming bone quality indices to premenopausal healthy control values2022 | First Faculty of Medicine
Loading network view...